StockWatch
·
Pharmaceuticals
Board Meeting7 Sept 2026, 08:10 pm

Gujarat Themis Biosyn Board to Consider NCD Fund Raising

AI Summary

Gujarat Themis Biosyn Ltd has announced that its Board of Directors will convene on September 10, 2026. The primary agenda item is to consider and approve a proposal for raising funds through the issuance of Non-Convertible Debentures (NCDs) via private placement. Concurrently, the company has closed its trading window for designated persons and their relatives, in compliance with SEBI's insider trading regulations, until further notice.

Key Highlights

  • Board meeting scheduled for September 10, 2026.
  • Proposal to raise funds via Non-Convertible Debentures.
  • NCDs to be issued through private placement.
  • Trading window closed for designated persons.